Jose Carmona

Insider Reports History

Location
Newtown Square, PA
Signature
/s/ Lisa Kallebo, Attorney-in-Fact for Jose Carmona
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jose Carmona:

Company Role Class Num Shares Value Price $ Report Date Ownership
ADC Therapeutics SA Chief Financial Officer Common Shares 488,656 $1,607,678 $3.29 06 Dec 2025 Direct
Rubius Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 143,750 31 Jan 2022 Direct
Rubius Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 34,500 31 Jan 2022 Direct

Insider Reports Filed by Jose Carmona

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADCT ADC Therapeutics SA 06 Dec 2025 1 -$175,146 4 Chief Financial Officer 09 Dec 2025, 17:09
ADCT ADC Therapeutics SA 13 Feb 2025 1 +$386,400 4 Chief Financial Officer 14 Feb 2025, 18:21
ADCT ADC Therapeutics SA 06 Dec 2024 1 -$150,578 4 Chief Financial Officer 09 Dec 2024, 20:37
ADCT ADC Therapeutics SA 02 Jan 2024 0 $0 3 Chief Financial Officer 02 Jan 2024, 20:09
/report/000117911022000696-carmona-jose-2022-01-31 Rubius Therapeutics, Inc. 31 Jan 2022 2 $0 4 Chief Financial Officer 01 Feb 2022, 20:20